efavirenz has been researched along with Kidney Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nordling, L | 1 |
| Ahmed-Jushuf, I; Arumainayagam, J; Carlin, EM; Chandramani, S; Das, S; Ghanem, M; Kumari, B; Pammi, M; Riddell, L | 1 |
| Bedimo, R; Myers, J; Rosenblatt, L | 1 |
| Borderi, M; Calza, L; Colangeli, V; Di Bari, MA; Magistrelli, E; Manfredi, R; Salvadori, C; Trapani, F; Viale, P | 1 |
| Dusak, BA; Goodwin, SD; Kuritzkes, DR; Rooney, JF; Skowron, G; Squires, KE; Stevens, M; Thompson, MA; Tolson, JM; Yuen, GJ | 1 |
| Mallal, S; Nolan, D; Reiss, P | 1 |
| Barbour, TD; Finlayson, RJ; Furlong, TJ | 1 |
| Klotman, PE; Rodriguez-Caprio, G; Wyatt, CM | 1 |
| Chen, H; Christ, DD; Davies, MH; Gan, LS; Gemzik, B; Gerson, RJ; Haley, PJ; Krahn, DF; Markwalder, JA; Meunier, PC; Miwa, GT; Mutlib, AE; Robertson, RT; Seitz, SP | 1 |
2 review(s) available for efavirenz and Kidney Diseases
| Article | Year |
|---|---|
Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection.
Topics: Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Bone Diseases; Clinical Trials as Topic; Cyclopropanes; Drug Interactions; Emtricitabine; HIV Infections; Humans; Incidence; Kidney Diseases; Tenofovir; Treatment Outcome | 2016 |
Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics.
Topics: Adenine; Alkynes; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardiovascular Diseases; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Kidney Diseases; Lopinavir; Metabolic Syndrome; Nevirapine; Organophosphonates; Oxazines; Pyrimidinones; Risk Factors; Tenofovir | 2005 |
1 trial(s) available for efavirenz and Kidney Diseases
| Article | Year |
|---|---|
Once-daily quadruple-drug therapy with adefovir dipivoxil, Lamivudine, Didanosine, and efavirenz in treatment-naive human immunodeficiency virus type 1-infected patients.
Topics: Adenine; Adult; Alkynes; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Kidney Diseases; Lamivudine; Male; Organophosphonates; Oxazines; Pulse Therapy, Drug; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Treatment Outcome | 2002 |
7 other study(ies) available for efavirenz and Kidney Diseases
| Article | Year |
|---|---|
How the genomics revolution could finally help Africa.
Topics: Africa; Alkynes; Anti-HIV Agents; Apolipoprotein L1; Apolipoproteins; Benzoxazines; Black People; Charities; Cyclopropanes; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Genetics, Medical; Genome-Wide Association Study; Genomics; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Kidney Diseases; Lipoproteins, HDL; National Institutes of Health (U.S.); Neoplasms; Oxazines; Piperazines; Polymorphism, Single Nucleotide; Precision Medicine; Public Health; Pyridones; Reverse Transcriptase Inhibitors; Stroke; Trypanosomiasis, African; United States; White People | 2017 |
Safety and efficacy of tenofovir/emtricitabine or abacavir/lamivudine in combination with efavirenz in treatment naïve HIV patients: a 5 year retrospective observational cohort study. (the TOKEN Study).
Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Cardiovascular Diseases; CD4 Lymphocyte Count; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Emtricitabine; Female; HIV Infections; Humans; Kidney Diseases; Lamivudine; Male; Middle Aged; Organophosphonates; Retrospective Studies; Tenofovir; Viral Load | 2013 |
Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/emtricitabine associated with efavirenz, atazanavir/ritonavir, or lopinavir/ritonavir.
Topics: Adenine; Adult; Alkynes; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Deoxycytidine; Emtricitabine; Female; Glomerular Filtration Rate; Glycosuria; HIV Infections; HIV Protease Inhibitors; Humans; Kidney Diseases; Lopinavir; Male; Middle Aged; Oligopeptides; Organophosphonates; Proteinuria; Pyridines; Retrospective Studies; Ritonavir; Tenofovir | 2013 |
Efavirenz-associated podocyte damage.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Infections; HIV-1; Humans; Kidney Diseases; Kidney Glomerulus; Male; Middle Aged; Oxazines; Podocytes | 2007 |
Efavirenz: innocent bystander or direct nephrotoxin?
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Infections; Humans; Kidney Diseases | 2007 |
The species-dependent metabolism of efavirenz produces a nephrotoxic glutathione conjugate in rats.
Topics: Alkynes; Animals; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Enzyme Inhibitors; Epithelial Cells; Gas Chromatography-Mass Spectrometry; Glutathione; Haplorhini; Humans; Isoxazoles; Kidney Diseases; Kidney Tubules; Male; Necrosis; Oxazines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors; Species Specificity | 2000 |
New drugs in development.
Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; CD4 Lymphocyte Count; Clinical Trials as Topic; Cyclopropanes; Dideoxynucleosides; Drug Therapy, Combination; Drugs, Investigational; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Imidazoles; Kidney Diseases; Lopinavir; Oxazines; Pyridines; Pyrimidinones; Reverse Transcriptase Inhibitors; Sulfonamides; Viral Load | 1998 |